(JHG) Janus Henderson - Overview
Stock: Equity Funds, Fixed-Income Funds, Balanced Funds, Private Equity, Real-Estate
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.78% |
| Yield on Cost 5y | 6.55% |
| Yield CAGR 5y | 1.47% |
| Payout Consistency | 97.8% |
| Payout Ratio | 27.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 19.0% |
| Relative Tail Risk | -9.20% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.31 |
| Alpha | -11.04 |
| Character TTM | |
|---|---|
| Beta | 1.387 |
| Beta Downside | 1.575 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.29% |
| CAGR/Max DD | 0.73 |
Description: JHG Janus Henderson January 08, 2026
Janus Henderson Group plc (NYSE:JHG) is a UK-based asset-management holding company that serves institutional, retail, and high-net-worth clients through a suite of equity, fixed-income, and balanced mutual funds, as well as private-equity and real-estate investments. Its product focus spans growth-capital, middle-market buyouts, and a broad set of sector exposures-including commercial services, logistics, consumer durables, hospitality, health care, financial services, REITs, and alternative-energy assets-across both public and private markets, with a particular emphasis on companies in China and India.
Key metrics as of the latest FY2023 filing show approximately $400 billion in assets under management (AUM), a net inflow of $9 billion for the year, and a dividend yield near 2.5 %. The firm’s revenue mix is roughly 55 % fee-based (management fees) and 45 % performance-based, reflecting a shift toward recurring fee structures amid industry pressure from passive alternatives. Macro drivers that materially affect Janus Henderson include global interest-rate trends (which influence fixed-income demand), the ongoing reallocation to ESG-aligned funds, and the growth of emerging-market capital flows, especially in India’s expanding middle-class consumer sector.
For a deeper, data-driven view of JHG’s valuation and risk profile, you may find it useful to explore the analytics available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 786.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -0.61 > 1.0 |
| NWC/Revenue: 15.12% < 20% (prev 90.81%; Δ -75.68% < -1%) |
| CFO/TA 0.08 > 3% & CFO 644.1m > Net Income 786.4m |
| Net Debt (-858.4m) to EBITDA (871.7m): -0.98 < 3 |
| Current Ratio: 1.60 > 1.5 & < 3 |
| Outstanding Shares: last quarter (150.4m) vs 12m ago -2.78% < -2% |
| Gross Margin: 70.30% > 18% (prev 0.69%; Δ 6961 % > 0.5%) |
| Asset Turnover: 39.94% > 50% (prev 32.12%; Δ 7.81% > 0%) |
| Interest Coverage Ratio: 33.31 > 6 (EBITDA TTM 871.7m / Interest Expense TTM 25.1m) |
Altman Z'' 1.93
| A: 0.06 (Total Current Assets 1.25b - Total Current Liabilities 784.3m) / Total Assets 8.29b |
| B: 0.14 (Retained Earnings 1.18b / Total Assets 8.29b) |
| C: 0.11 (EBIT TTM 836.2m / Avg Total Assets 7.78b) |
| D: 0.35 (Book Value of Equity 1.07b / Total Liabilities 3.01b) |
| Altman-Z'' Score: 1.93 = BBB |
Beneish M -2.63
| DSRI: 0.83 (Receivables 470.3m/423.4m, Revenue 3.11b/2.33b) |
| GMI: 0.98 (GM 70.30% / 69.14%) |
| AQI: 1.50 (AQ_t 0.84 / AQ_t-1 0.56) |
| SGI: 1.33 (Revenue 3.11b / 2.33b) |
| TATA: 0.02 (NI 786.4m - CFO 644.1m) / TA 8.29b) |
| Beneish M-Score: -2.63 (Cap -4..+1) = A |
What is the price of JHG shares?
Over the past week, the price has changed by +0.19%, over one month by +0.37%, over three months by +12.41% and over the past year by +9.35%.
Is JHG a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 8
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the JHG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 50.1 | 4% |
| Analysts Target Price | 50.1 | 4% |
| ValueRay Target Price | 56 | 16.1% |
JHG Fundamental Data Overview February 01, 2026
P/E Forward = 10.7066
P/S = 2.7913
P/B = 1.499
P/EG = 0.9648
Revenue TTM = 3.11b USD
EBIT TTM = 836.2m USD
EBITDA TTM = 871.7m USD
Long Term Debt = 395.4m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 395.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -858.4m USD (from netDebt column, last quarter)
Enterprise Value = 6.79b USD (7.43b + Debt 395.5m - CCE 1.04b)
Interest Coverage Ratio = 33.31 (Ebit TTM 836.2m / Interest Expense TTM 25.1m)
EV/FCF = 10.71x (Enterprise Value 6.79b / FCF TTM 634.0m)
FCF Yield = 9.34% (FCF TTM 634.0m / Enterprise Value 6.79b)
FCF Margin = 20.42% (FCF TTM 634.0m / Revenue TTM 3.11b)
Net Margin = 25.33% (Net Income TTM 786.4m / Revenue TTM 3.11b)
Gross Margin = 70.30% ((Revenue TTM 3.11b - Cost of Revenue TTM 922.2m) / Revenue TTM)
Gross Margin QoQ = 73.19% (prev 69.06%)
Tobins Q-Ratio = 0.82 (Enterprise Value 6.79b / Total Assets 8.29b)
Interest Expense / Debt = 1.54% (Interest Expense 6.10m / Debt 395.5m)
Taxrate = 8.23% (45.0m / 547.1m)
NOPAT = 767.4m (EBIT 836.2m * (1 - 8.23%))
Current Ratio = 1.60 (Total Current Assets 1.25b / Total Current Liabilities 784.3m)
Debt / Equity = 0.07 (Debt 395.5m / totalStockholderEquity, last quarter 5.28b)
Debt / EBITDA = -0.98 (Net Debt -858.4m / EBITDA 871.7m)
Debt / FCF = -1.35 (Net Debt -858.4m / FCF TTM 634.0m)
Total Stockholder Equity = 4.83b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.11% (Net Income 786.4m / Total Assets 8.29b)
RoE = 16.27% (Net Income TTM 786.4m / Total Stockholder Equity 4.83b)
RoCE = 15.99% (EBIT 836.2m / Capital Employed (Equity 4.83b + L.T.Debt 395.4m))
RoIC = 15.04% (NOPAT 767.4m / Invested Capital 5.10b)
WACC = 10.53% (E(7.43b)/V(7.83b) * Re(11.02%) + D(395.5m)/V(7.83b) * Rd(1.54%) * (1-Tc(0.08)))
Discount Rate = 11.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.87%
[DCF Debug] Terminal Value 70.08% ; FCFF base≈620.4m ; Y1≈644.3m ; Y5≈735.7m
Fair Price DCF = 63.14 (EV 8.57b - Net Debt -858.4m = Equity 9.43b / Shares 149.4m; r=10.53% [WACC]; 5y FCF grow 4.04% → 2.90% )
EPS Correlation: 78.20 | EPS CAGR: 30.07% | SUE: 4.0 | # QB: 7
Revenue Correlation: 65.03 | Revenue CAGR: 19.08% | SUE: 2.13 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.96 | Chg30d=+0.002 | Revisions Net=-1 | Analysts=5
EPS current Year (2026-12-31): EPS=4.36 | Chg30d=-0.018 | Revisions Net=+2 | Growth EPS=-8.7% | Growth Revenue=-2.7%
EPS next Year (2027-12-31): EPS=4.76 | Chg30d=-0.007 | Revisions Net=+3 | Growth EPS=+9.0% | Growth Revenue=+4.9%